Lung Cancer

Share this page:

The CyberKnife® Radiosurgery Solution: Early stage Bronchogenic Carcinoma

Radiation Dose/Therapeutic Margin

Due to its unique tumor tracking capability, the CyberKnife® device has a published accuracy of one millimeter (14), with a much sharper dose fall off at the target volume margin, effectively rendering the high dose radiation margin more “scalpel-like,” allowing a far smaller normal tissue expansion around the target lesion. This margin reduction causes much better sparing of critical adjacent tissues from the high dose volume, allowing a substantial radiobiologic dose escalation within the target volume, resulting in the published safe delivery of >=60Gy total dose in 3 treatments, delivered in less than one week (12).

Large radiation dose per treatment is known as hypofractionation, and represents a tissue ablative radiation approach, safely administered only with an extremely precise device. Delivering 60 Gy in 3 treatments instead of the customary 30 treatments results in a radiation biological dose equivalent that is 50-100% larger, depending upon the biologic characteristics of the targeted cell population, translating to a higher probability of complete tumor eradication.

lung cancer, bronchogenic carcinoma

Image adapted from "Robotic Radiosurgery" - First Edition

Written by Donald B. Fuller, M.D. – Radiation Oncologist

Central San Diego

5395 Ruffin Road, Suite 103
San Diego, CA 92123
(858) 505-4100
(800) 470-1256

North County San Diego

477 N. El Camino Real, Suite D-101
Encinitas, CA. 92024
(760) 230-6706
(800) 470-1256

2010 © All Rights Reserved | www.sdcyberknife.com